Tag: pharmaceuticals
-
Contracts Awarded for GI Tract Radiation Syndrome Drugs
The Biomedical Advanced Research and Development Authority (BARDA) awarded two contracts for further research and development of drugs to treat gastrointestinal (GI) tract injuries associated with acute radiation syndrome. BARDA is an agency of the U.S. Department of Health and Human Services. The contracts are part of BARDA’s program to develop tools and drugs to…
-
Cold Electrons Aid Nanoscale Imaging and Processes
Physicists at University of Melbourne in Australia have developed a new source of ultra-cold electrons that can improve the quality and speed of nanoscale imaging for processes such as drug and materials development. The team’s findings appear online in the journal Nature Physics (paid subscription required). The researchers led by Melbourne physics professor Robert Scholten…
-
Baxter Sets Up Venture Fund for New Therapies
Baxter International in Deerfield, Illinois has established Baxter Ventures to invest in promising early-stage companies developing therapies that complement Baxter’s product lines. Baxter Ventures will make up to $200 million in equity investments and report to Norbert Riedel, the company’s chief scientific officer. Baxter is a developer of medical devices, pharmaceuticals, and biotechnology solutions. The…
-
FDA Alerting Pharmas Over Work of Contract Research Company [UPDATED]
The Food and Drug Administration has notified pharmaceutical companies that hired contract research organization Cetero Research of Houston, Texas that the work done by Cetero may need to be redone or confirmed. The alert to pharmaceutical companies follows an FDA letter sent yesterday to Cetero identifying problems in the company’s research, including falsification of entries…
-
FDA Outlines Regulatory Science Needs for Drug Evaluations
The Food and Drug Administration published its proposed needs for regulatory science in the agency’s Center for Drug Evaluation and Research (CDER), its main drug regulating division. The document is available for public review and comments, which close 60 days following the 21 July 2011 publication. CDER regulates over-the-counter and prescription drugs, including biological therapeutics…
-
Prostate Cancer Compound Granted U.S. Patent
Adamis Pharmaceuticals Corp. in San Diego, California says the technology behind its cancer drug candidate has received a patent from the U.S. Patent and Trademark Office. Claims in patent 7863324 “Chroman-Derived Compounds for the Treatment of Cancer” include methods for inhibiting the growth of prostate cancer cells, delaying the progression of prostate cancer, and preventing…
-
Agilent, Singapore Institute Launch Drug Screening Center
Agilent Technologies in Santa Clara, California and Singapore’s Agency for Science, Technology and Research (A*STAR) unveiled a comprehensive drug screening platform for biomedical researchers. The service, called the Singapore Screening Centre, will reside in A*STAR’s Experimental Therapeutics Centre. Agilent and A*STAR say the platform can conduct high-throughput screenings to identify potential drug candidates against diseases,…
-
FDA Approves Blood Thinning Drug for Heart Disease
The Food and Drug Administration approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS). Brilinta is a product of AstraZeneca in Wilmington, Delaware. Brilinta helps prevent the formation of new blood clots, thus maintaining blood flow in the body to help reduce the risk…
-
Vaccine Against Heroin High Tested in Animals
Scientists at the Scripps Research Institute in San Diego, California have developed a vaccine against a heroin-induced high and tested its potential in lab rats. Their findings appear online in the Journal of Medicinal Chemistry (paid subscription required). The team led by chemistry researcher Kim Janda devised a vaccine that generates antibodies to stop heroin…
-
Roche Acquires Cancer Diagnostics Company
The global pharmaceutical company Roche has acquired mtm laboratories AG in Heidelberg, Germany, which specializes in detection and diagnosis of cervical cancer. mtm will become part of Roche’s Ventana Medical Systems Inc. business unit. Under the agreement, Roche will pay mtm shareholders an upfront payment of EUR 130 million (USD 182 million) as well as…